基于多糖,和蛋白质的静血材料的最新研究进展:一篇综述
Hanjie Shao1, Xiang Wu1, Ying Xiao2
1Ningbo Medical Center Li Huili Hospital, Health Science Center, Ningbo University, Ningbo 315000, PR China; Zhejiang International Scientific and Technological Cooperative Base of Biomedical Materials and Technology, Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, PR China; Ningbo Cixi Institute of Biomedical Engineering, Ningbo 315300, PR China.
International journal of biological macromolecules
|January 27, 2024
概括
从多糖,和蛋白质开发先进的静血材料对于改善紧急出血控制至关重要. 这些新型生物材料比传统方法更有效,解决了医学中的关键需求.
科学领域:
- 生物材料科学 生物材料科学
- 血液静止研究 血液静止研究
- 医疗应急响应医疗应急响应
背景情况:
- 在各种临床情景中,出血存在严重的危及生命的风险.
- 目前的临床血静止方法通常会产生低于最佳的结果.
- 需要先进的静血材料来改善患者的预后.
研究的目的:
- 审查基于多糖,和蛋白质的血液静止材料的最新进展.
- 阐明这些新型生物材料的设计原理和静血机制.
- 总结血液静止材料开发的优势,局限性和未来的挑战.
主要方法:
- 文献综述,重点关注过去五年开发的血液静止材料.
- 血液静止机制的分析,包括凝血过程和物质相互作用.
- 基于来源 (多糖,,蛋白质) 和形式 (粘合剂,密封剂,带,粉末,海绵) 的材料分类.
主要成果:
- 来自多糖,和蛋白质的新型静血材料显示出高效.
- 这些材料利用增强或互动的静血机制来提高性能.
- 关键形式包括粘合剂,密封剂,带,粉末和海绵,每个都有特定的应用.
结论:
- 基于多糖,和蛋白质的材料代表了静血技术的重大进步.
- 了解它们的设计和机制是优化出血控制的关键.
- 需要继续进行研究,以克服现有的挑战,并进一步完善静血材料的应用.
相关概念视频
Introduction to Hemostasis
7.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
Extrinsic and Intrinsic Pathways of Hemostasis
7.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.7K
Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K


